Viking Global Investors LP Standard Biotools Inc. Transaction History
Viking Global Investors LP
- $29.9 Billion
- Q1 2025
A detailed history of Viking Global Investors LP transactions in Standard Biotools Inc. stock. As of the latest transaction made, Viking Global Investors LP holds 58,651,170 shares of LAB stock, worth $68 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
58,651,170
Previous 58,651,170
-0.0%
Holding current value
$68 Million
Previous $103 Million
38.29%
% of portfolio
0.21%
Previous 0.35%
Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
150Shares Held
277MCall Options Held
6KPut Options Held
36.6K-
Casdin Capital, LLC New York, NY76.1MShares$88.2 Million9.61% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$25.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$20 Million0.0% of portfolio
-
Morgan Stanley New York, NY10.7MShares$12.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA7.21MShares$8.36 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $91.2M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...